mortality/aging
• 50% of mice survive to 3 months of age and more than 80% of mice die after 6 months of age
|
behavior/neurological
• mutants develop progressive neurological symptoms and severe behavioral deficits starting at 6-8 weeks of age
|
• reduction in grooming that results in a disheveled appearance
|
• 6 month old mice approaching a pen or rod from above are unable to grab it and exhibit a clasping behavior
|
• wide-based hindlimbs to stabilize the body in a resting position
• mildly affected mice at 3 months of age show a minced gait with mild disturbances and a reduced distance between each step
• at end stage of disease, mutants have a severely affected gait and are almost unable to walk
|
• reduction in distance between each step
|
• mutants exhibit reduced activity, with mutants at end stage of disease almost completely inactive
|
growth/size/body
nervous system
• formation of contracted or empty baskets around Purkinje cells
|
• shrinkage of approximately 50-80% of Purkinje cells, characterized by an increase of the electron density of the cytoplasm and the karyoplasm and by irregular alterations of the cytoplasm and nuclear shapes
|
• ataxin-3 and ubiquitin-positive neuronal intranuclear inclusion bodies are present in the brain
|
• content of dopamine metabolites 3,4-dihyddroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) are reduced in the striatum, however dopamine levels are normal
• turnover rate for dopamine and serotonin are reduced
|
skeleton
hearing/vestibular/ear
N |
• normal hearing and cochlear outer hair cell function
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Machado-Joseph disease | DOID:1440 |
OMIM:109150 |
J:122993 |